|
Search
Collections
Benchmarks
Upload document
Product
Novolin
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Type 1 Diabetes
Clinical trial
An Open Label,Randomized,Comparison of the Immunogenicity and Safety of Wockhardt's Human Insulin Basal Bolus Regimen With the Novo Nordisk's Yeast Based Human Insulin Basal Bolus Regimens, Marketed in United States, in Type 1 Diabetics.
Status: Terminated
, Estimated PCD: 2013-04-01
